1

Matters of Administration

1.1

Welcome and apologies

1.2

Minutes of the 162nd MARC meeting

1.3

Declaration of potential conflicts of interest

2

Medsafe Pharmacovigilance Activities

2.1

Report on standing agenda items

2.2

Medsafe pharmacovigilance activities

2.3

Prescriber Update

2.4

Quarterly summary of Medsafe early warning system communications

3

Pharmacovigilance Reports

3.1

Matters referred to the MARC under section 36 of the Medicines Act 1981

No items.

3.2

Matters referred to the MARC by Medsafe

3.2.1

Nitrofurantoin use in renal impairment

3.2.2

Cefalosporins and cross reactivity

3.2.3

Gardasil and autoimmune diseases

3.2.4

Statins and interstitial lung disease

4

Matters Arising from the NZ Pharmacovigilance Centre

4.1

CARM Quarterly Report

5

Other Business

5.1

Therapeutic Products Regulation Project update